908 Devices Inc. (NASDAQ:MASS – Get Free Report) Director Christopher Brown sold 30,000 shares of the company’s stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $9.00, for a total transaction of $270,000.00. Following the transaction, the director directly owned 895,559 shares of the company’s stock, valued at approximately $8,060,031. This trade represents a 3.24% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
908 Devices Stock Down 5.8%
Shares of NASDAQ:MASS traded down $0.52 during midday trading on Friday, hitting $8.41. 336,962 shares of the stock traded hands, compared to its average volume of 297,617. The stock has a market capitalization of $317.98 million, a PE ratio of -8.41 and a beta of 0.57. The business’s 50 day moving average is $6.98 and its two-hundred day moving average is $6.43. 908 Devices Inc. has a one year low of $5.03 and a one year high of $9.34.
908 Devices (NASDAQ:MASS – Get Free Report) last issued its quarterly earnings data on Tuesday, March 3rd. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.06) by $0.01. 908 Devices had a negative net margin of 62.40% and a negative return on equity of 14.03%. The firm had revenue of $17.38 million during the quarter, compared to the consensus estimate of $16.19 million. As a group, sell-side analysts forecast that 908 Devices Inc. will post -0.38 earnings per share for the current year.
Hedge Funds Weigh In On 908 Devices
Analyst Ratings Changes
A number of research firms recently issued reports on MASS. Weiss Ratings downgraded shares of 908 Devices from a “hold (c-)” rating to a “sell (d-)” rating in a research note on Monday, May 11th. Wall Street Zen downgraded shares of 908 Devices from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, 908 Devices currently has a consensus rating of “Hold” and a consensus price target of $12.00.
Check Out Our Latest Stock Report on 908 Devices
908 Devices Company Profile
908 Devices Inc (NASDAQ: MASS) is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company’s core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.
Key products in 908 Devices’ portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations.
See Also
- Five stocks we like better than 908 Devices
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
Receive News & Ratings for 908 Devices Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 908 Devices and related companies with MarketBeat.com's FREE daily email newsletter.
